4BIO Capital - Redpin Therapeutics secures initial closing of $15.5 million in Series A financing

Redpin Therapeutics secures initial closing of $15.5 million in Series A financing. 4BIO Capital and Arkin Bio Ventures lead first close joined by Takeda Ventures and existing investors.